+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Rapid Diagnostics Market 2021-2031 by Product, Prescription, Platform, Application, End User, and Country: Trend Forecast and Growth Opportunity

  • PDF Icon

    Report

  • 127 Pages
  • December 2022
  • Region: Europe
  • GMD Research
  • ID: 5712807
Europe Rapid Diagnostics was valued at $ 9,950.1 million in 2021 and will grow by 5.6% annually over 2021-2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, increase in awareness regarding early diagnosis of disease, and emerging technological innovations.

Highlighted with 38 tables and 65 figures, this 127-page report “Europe Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Europe Rapid Diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe Rapid Diagnostics market in every aspect of the classification from perspectives of Product, Prescription, Platform, Application, End User, and Country.

Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Consumables
  • Analyzers/Instruments

Based on Prescription, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Professional Diagnostics
  • OTC Based Testing

By Platform, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Immunoassays

  • Lateral Flow Assays
  • Serological Assays
  • Other Immunoassays

Molecular Detection

  • Polymerase Chain Reaction (PCR)
  • Other Molecular Detection Tests
  • Other Platforms

By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Blood Glucose Testing
  • Cardiometabolic Testing
  • Infectious Disease Testing
  • COVID-19 Testing
  • Healthcare-associated Infections (HAI) Testing
  • Hepatitis Testing
  • Tropical Diseases Testing
  • HIV Testing
  • Influenza Testing
  • Sexually Transmitted Diseases (STD) Testing
  • Other Infectious Diseases Testing
  • Blood Coagulation Testing
  • Hematology Testing
  • Cancer Testing
  • Drug Abuse Testing
  • Pregnancy & Fertility Testing
  • Other Applications

By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Hospitals & Clinics
  • Laboratories
  • Individuals/Homecare
  • Other End Users

Geographically, the following national/local markets are fully investigated:

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Prescription and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

  • Abbott Diagnostics
  • ACON Laboratories
  • Becton Dickinson and Co.
  • BioMérieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • GlySens Inc.
  • Meridian Bioscience Inc.
  • OraSure Technologies Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Frequently Asked Questions about the European Rapid Diagnostics Market

What is the estimated value of the European Rapid Diagnostics Market?

The European Rapid Diagnostics Market was estimated to be valued at $9950.1 Million in 2021.

What is the growth rate of the European Rapid Diagnostics Market?

The growth rate of the European Rapid Diagnostics Market is 5.6%, with an estimated value of $17146.1 Million by 2031.

What is the forecasted size of the European Rapid Diagnostics Market?

The European Rapid Diagnostics Market is estimated to be worth $17146.1 Million by 2031.

Who are the key companies in the European Rapid Diagnostics Market?

Key companies in the European Rapid Diagnostics Market include Abbott Diagnostics, ACON Laboratories, Becton Dickinson and Co., BioMérieux S.A., Bio, Rad Laboratories, Inc., Chembio Diagnostic Systems, Danaher Corp. and GlySens Inc..

Table of Contents

1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 Segmentation of Europe Market by Product
3.1 Market Overview by Product
3.2 Consumables
3.3 Analyzers/Instruments
4 Segmentation of Europe Market by Prescription
4.1 Market Overview by Prescription
4.2 Professional Diagnostics
4.3 OTC Based Testing
5 Segmentation of Europe Market by Platform
5.1 Market Overview by Platform
5.2 Immunoassays
5.2.1 Lateral Flow Assays
5.2.2 Serological Assays
5.2.3 Other Immunoassays
5.3 Molecular Detection
5.3.1 Polymerase Chain Reaction (PCR)
5.3.2 Other Molecular Detection Tests
5.4 Other Platforms
6 Segmentation of Europe Market by Application
6.1 Market Overview by Application
6.2 Blood Glucose Testing
6.3 Cardiometabolic Testing
6.4 Infectious Disease Testing
6.4.1 COVID-19 Testing
6.4.2 Healthcare-associated Infections (HAI) Testing
6.4.3 Hepatitis Testing
6.4.4 Tropical Diseases Testing
6.4.5 HIV Testing
6.4.6 Influenza Testing
6.4.7 Sexually Transmitted Diseases (STD) Testing
6.4.8 Other Infectious Diseases Testing
6.5 Blood Coagulation Testing
6.6 Hematology Testing
6.7 Cancer Testing
6.8 Drug Abuse Testing
6.9 Pregnancy & Fertility Testing
6.10 Other Applications
7 Segmentation of Europe Market by End User
7.1 Market Overview by End User
7.2 Hospitals & Clinics
7.3 Laboratories
7.4 Individuals/Homecare
7.5 Other End Users
8 European Market 2021-2031 by Country
8.1 Overview of European Market
8.2 Germany
8.3 U.K.
8.4 France
8.5 Spain
8.6 Italy
8.7 Netherlands
8.8 Rest of European Market
9 Competitive Landscape
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
  • Abbott Diagnostics
  • ACON Laboratories
  • Becton Dickinson and Co.
  • BioMérieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • GlySens Inc.
  • Meridian Bioscience Inc.
  • OraSure Technologies Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc
List of Tables
Table 1. Snapshot of Europe Rapid Diagnostics Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Main Product Trends and Market Opportunities in Europe Rapid Diagnostics Market
Table 6. Europe Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 7. Europe Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 8. Europe Rapid Diagnostics Market by Platform, 2021-2031, $ mn
Table 9. Europe Rapid Diagnostics Market: Immunoassays by Type, 2021-2031, $ mn
Table 10. Europe Rapid Diagnostics Market: Molecular Detection by Type, 2021-2031, $ mn
Table 11. Europe Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 12. Europe Rapid Diagnostics Market: Infectious Disease Testing by Type, 2021-2031, $ mn
Table 13. Europe Rapid Diagnostics Market by End User, 2021-2031, $ mn
Table 14. Europe Rapid Diagnostics Market by Country, 2021-2031, $ mn
Table 15. Germany Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 16. Germany Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 17. Germany Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 18. U.K. Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 19. U.K. Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 20. U.K. Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 21. France Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 22. France Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 23. France Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 24. Spain Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 25. Spain Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 26. Spain Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 27. Italy Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 28. Italy Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 29. Italy Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 30. Netherlands Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 31. Netherlands Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 32. Netherlands Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 33. Rapid Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn
Table 34. Rapid Diagnostic Analyzers by Vendor
Table 35. Recent Product Launches, 2018-2021
Table 36. Abbott Diagnostics: Company Snapshot
Table 37. Abbott Diagnostics: Business Segmentation
Table 38. Abbott Diagnostics: Product Portfolio
List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Europe Rapid Diagnostics Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Europe Rapid Diagnostics Market
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060
Figure 10. Primary Restraints and Impact Factors of Europe Rapid Diagnostics Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of Europe Rapid Diagnostics Market
Figure 13. Breakdown of Europe Rapid Diagnostics Market by Product, 2021-2031, % of Revenue
Figure 14. Europe Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%)
Figure 15. Europe Rapid Diagnostics Market by Product: Consumables, 2021-2031, $ mn
Figure 16. Europe Rapid Diagnostics Market by Product: Analyzers/Instruments, 2021-2031, $ mn
Figure 17. Breakdown of Europe Rapid Diagnostics Market by Prescription, 2021-2031, % of Sales Revenue
Figure 18. Europe Addressable Market Cap in 2022-2031 by Prescription, Value ($ mn) and Share (%)
Figure 19. Europe Rapid Diagnostics Market by Prescription: Professional Diagnostics, 2021-2031, $ mn
Figure 20. Europe Rapid Diagnostics Market by Prescription: OTC Based Testing, 2021-2031, $ mn
Figure 21. Breakdown of Europe Rapid Diagnostics Market by Platform, 2021-2031, % of Sales Revenue
Figure 22. Europe Addressable Market Cap in 2022-2031 by Platform, Value ($ mn) and Share (%)
Figure 23. Europe Rapid Diagnostics Market by Platform: Immunoassays, 2021-2031, $ mn
Figure 24. Europe Rapid Diagnostics Market by Immunoassays: Lateral Flow Assays, 2021-2031, $ mn
Figure 25. Europe Rapid Diagnostics Market by Immunoassays: Serological Assays, 2021-2031, $ mn
Figure 26. Europe Rapid Diagnostics Market by Immunoassays: Other Immunoassays, 2021-2031, $ mn
Figure 27. Europe Rapid Diagnostics Market by Platform: Molecular Detection, 2021-2031, $ mn
Figure 28. Europe Rapid Diagnostics Market by Molecular Detection: Polymerase Chain Reaction (PCR), 2021-2031, $ mn
Figure 29. Europe Rapid Diagnostics Market by Molecular Detection: Other Molecular Detection Tests, 2021-2031, $ mn
Figure 30. Europe Rapid Diagnostics Market by Platform: Other Platforms, 2021-2031, $ mn
Figure 31. Breakdown of Europe Rapid Diagnostics Market by Application, 2021-2031, % of Revenue
Figure 32. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 33. Europe Rapid Diagnostics Market by Application: Blood Glucose Testing, 2021-2031, $ mn
Figure 34. Europe Rapid Diagnostics Market by Application: Cardiometabolic Testing, 2021-2031, $ mn
Figure 35. Europe Rapid Diagnostics Market by Application: Infectious Disease Testing, 2021-2031, $ mn
Figure 36. Europe Rapid Diagnostics Market by Infectious Disease Testing: COVID-19 Testing, 2021-2031, $ mn
Figure 37. Europe Rapid Diagnostics Market by Infectious Disease Testing: Healthcare-associated Infections (HAI) Testing, 2021-2031, $ mn
Figure 38. Europe Rapid Diagnostics Market by Infectious Disease Testing: Hepatitis Testing, 2021-2031, $ mn
Figure 39. Europe Rapid Diagnostics Market by Infectious Disease Testing: Tropical Diseases Testing, 2021-2031, $ mn
Figure 40. Europe Rapid Diagnostics Market by Infectious Disease Testing: HIV Testing, 2021-2031, $ mn
Figure 41. Europe Rapid Diagnostics Market by Infectious Disease Testing: Influenza Testing, 2021-2031, $ mn
Figure 42. Europe Rapid Diagnostics Market by Infectious Disease Testing: Sexually Transmitted Diseases (STD) Testing, 2021-2031, $ mn
Figure 43. Europe Rapid Diagnostics Market by Infectious Disease Testing: Other Infectious Diseases Testing, 2021-2031, $ mn
Figure 44. Europe Rapid Diagnostics Market by Application: Blood Coagulation Testing, 2021-2031, $ mn
Figure 45. Europe Rapid Diagnostics Market by Application: Hematology Testing, 2021-2031, $ mn
Figure 46. Europe Rapid Diagnostics Market by Application: Cancer Testing, 2021-2031, $ mn
Figure 47. Europe Rapid Diagnostics Market by Application: Drug Abuse Testing, 2021-2031, $ mn
Figure 48. Europe Rapid Diagnostics Market by Application: Pregnancy & Fertility Testing, 2021-2031, $ mn
Figure 49. Europe Rapid Diagnostics Market by Application: Other Applications, 2021-2031, $ mn
Figure 50. Breakdown of Europe Rapid Diagnostics Market by End User, 2021-2031, % of Revenue
Figure 51. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 52. Europe Rapid Diagnostics Market by End User: Hospitals & Clinics, 2021-2031, $ mn
Figure 53. Europe Rapid Diagnostics Market by End User: Laboratories, 2021-2031, $ mn
Figure 54. Europe Rapid Diagnostics Market by End User: Individuals/Homecare, 2021-2031, $ mn
Figure 55. Europe Rapid Diagnostics Market by End User: Other End Users, 2021-2031, $ mn
Figure 56. Breakdown of European Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 57. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 58. Rapid Diagnostics Market in Germany, 2021-2031, $ mn
Figure 59. Rapid Diagnostics Market in U.K., 2021-2031, $ mn
Figure 60. Rapid Diagnostics Market in France, 2021-2031, $ mn
Figure 61. Rapid Diagnostics Market in Spain, 2021-2031, $ mn
Figure 62. Rapid Diagnostics Market in Italy, 2021-2031, $ mn
Figure 63. Rapid Diagnostics Market in Netherlands, 2021-2031, $ mn
Figure 64. Rapid Diagnostics Market in Rest of Europe, 2021-2031, $ mn
Figure 65. Growth Stage of Europe Rapid Diagnostics Industry over the Forecast Period

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Diagnostics
  • ACON Laboratories
  • Becton Dickinson and Co.
  • BioMérieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • GlySens Inc.
  • Meridian Bioscience Inc.
  • OraSure Technologies Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc

Methodology

Loading
LOADING...